Feasibility

PRA's Feasibility group provides comprehensive feasibility assessments for clinical trials and drug development programs worldwide.

Our feasibility team works with the following in-house experts to distribute and collect confidentiality agreements and feasibility questionnaires at the local level:

• Investigator Relations
• Medical Affairs
• Scientific Affairs
• Regulatory Affairs

Using global resources to conduct feasibility studies allows PRA to identify the most suitable regions and the most appropriate clinics and patient populations. This is a valuable service that accelerates product development and provides savings in time and money.

A feasibility study provides investigator-reported feedback describing the following information:

• Regional standards of care
• Ethical or cultural issues
• Feedback concerning the protocol design
• Competing studies
• Potential regulatory issues
• Patient availability
• Investigator and site experience
• Overall study interest